Your browser doesn't support javascript.
loading
Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants.
Lin, Yu-Jung; Sundhar, Navaneethan; Devi, Hema Sri; Pien, Hsueh-Fa; Wen, Shina Fong-Mei; Sheu, Jenn-Line; Tsai, Bruce Chi-Kang; Huang, Chih-Yang.
Affiliation
  • Lin YJ; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Sundhar N; School of Post-Baccalaureate Chinese Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Devi HS; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Pien HF; Graduate Institute of Biomedical Sciences, School of Medicine, China Medical University, Taichung, Taiwan.
  • Wen SF; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Sheu JL; TOMA Biotechnology CO., LTD, Taipei, Taiwan.
  • Tsai BC; TOMA Biotechnology CO., LTD, Taipei, Taiwan.
  • Huang CY; TOMA Biotechnology CO., LTD, Taipei, Taiwan.
Heliyon ; 9(9): e20011, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37809843
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Taiwán Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Taiwán Country of publication: Reino Unido